JTS2400107 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400109 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400106 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400110 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400104 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Us Inc;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400105 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
JTS2400108 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
CXSB2300105 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
CXSL2000373 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
CXSB2300106 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
CXSL2000372 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
CXSS1900042 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
JXSS1000007 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-09-15 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2012-08-28 | view |
JXSL0800021 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2008-08-13 | Baxter S.A. | Baxter SA | Certificate Issued | 2010-12-27 | view |
JYSB2400251 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB1500127 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-08 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-08-12 | view |
JYSZ1800032 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2018-07-20 | | Bayer Healthcare LLC | Certificate Issued | 2019-06-03 | view |
JYSZ2200030 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSB1400185 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2014-09-01 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2014-11-25 | view |
JYSB2100025 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-01-21 | view |